抗缪勒氏管激素诊断多囊卵巢综合征的价值分析

Value of Anti-Mullerian Hormone in Diagnosis of Polycystic Ovary Syndrome

目的:探讨抗缪勒氏管激素(AMH)诊断多囊卵巢综合征(PCOS)的临床价值。方法:选择2017年5月—2018年5月43例PCOS患者作为研究组,其中23例患者为高雄激素型(研究组Ⅰ组),20患者为非高雄激素型(研究Ⅱ组),选择同期43例健康体验者作为对照组。比较三组AMH、FSH和LH水平。结果:AMH比较,研究组高于对照组(P <0. 05),研究组Ⅰ组高于研究Ⅱ组(P <0. 05)。FSH比较,研究组和对照组比较差异无统计学意义(P> 0. 05),研究组Ⅰ组和研究Ⅱ组差异无统计学意义(P> 0. 05)。LH比较,研究组高于对照组(P <0. 05),研究Ⅰ组高于研究Ⅱ组(P <0. 05)。结论:PCOS患者的血清AMH水平显著升高,且高雄激素型患者的血清AMH明显高于非高雄激素型患者,是研究和诊断PCOS的重要指标。

Objective:To investigate the clinical value of anti-Mullerian hormone(AMH)in diagnosis of polycystic ovary syndrome(PCOS).Methods:43 patients with PCOS,selected from May 2017 to May 2018,were the study group,23 patients with high androgen PCOS were the study groupⅠ,20 cases with non high androgen PCOS were the study groupⅡ,and 43 cases of health experience were the control group,which were selected from the same period.The levels of AMH,FSH and LH were compared in the three groups.Results:Compared with AMH,the study group was higher than that in the control group(P<0.05),and the study groupⅠwas higher than that in the study groupⅡ(P<0.05).There was no significant difference in the FSH between the study group and the control group(P>0.05),and there was no significant difference between the study groupⅠand the study groupⅡ(P>0.05).Compared with LH,the study group was higher than that in the control group(P<0.05),and the study groupⅠwas higher than that in the study groupⅡ(P<0.05).Conclusion:The level of serum AMH in patients with PCOS was significantly higher,and the serum AMH in patients with high androgen PCOS was significantly higher than that in patients with non high androgen PCOS.AMH was an important index for the study and diagnosis of PCOS.